Laura Rodriguez Gallego
Direktor/Vorstandsmitglied bei Onechain Immunotherapeutics
Aktive Positionen von Laura Rodriguez Gallego
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Invivo Capital Partners SGEIC SA
 Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Private Equity Investor | 01.01.2018 | - |
Telomere Therapeutics SL
 Telomere Therapeutics SL Pharmaceuticals: MajorHealth Technology Telomere Technologies provides telomere technology services. The company is headquartered in Spain. | Direktor/Vorstandsmitglied | 01.04.2024 | - |
Onechain Immunotherapeutics
 Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | Direktor/Vorstandsmitglied | 01.01.2022 | - |
Karriereverlauf von Laura Rodriguez Gallego
Ausbildung von Laura Rodriguez Gallego
| University of Barcelona | Doctorate Degree |
| Universitat Autònoma de Barcelona | Undergraduate Degree |
Statistik
International
| Spanien | 6 |
Operativ
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Finance |
Telomere Therapeutics SL
Telomere Therapeutics SL Pharmaceuticals: MajorHealth Technology Telomere Technologies provides telomere technology services. The company is headquartered in Spain. | Health Technology |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | Health Technology |
- Börse
- Insiders
- Laura Rodriguez Gallego
- Erfahrung
